» Articles » PMID: 34108093

Clinical Features and Psychological Impact of Celiac Disease at Diagnosis

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2021 Jun 10
PMID 34108093
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: We aimed to describe the socio-demographic, behavioral and clinical profiles of adult patients with newly diagnosed celiac disease (CeD) and their possible association with QoL and psychological symptoms.

Methods: Adults newly diagnosed with CeD and residents in the Veneto region were included. Their sociodemographic characteristics, clinical presentation, mode of diagnosis, duration of symptoms before diagnosis and comorbidities were recorded. All patients completed the Beck Depression Inventory (BDI), State-Trait Anxiety Inventory (STAI) and Short Form Health Survey (SF-36) questionnaires.

Results: Between 2016 and 2019, 110 CeD patients (81% females, mean age 37.5) were recruited. At diagnosis, patients were categorized into classical (n = 56), nonclassical CeD (n = 49) and asymptomatic (n = 5) groups. Patients with classical presentation had a lower QoL than nonclassical patients, who were found to be more depressed. We observed a diagnosis delay of more than 7 months in more than 60% of patients with both classical and nonclassical presentations and we found that a longer duration of GI symptoms decreased the self-reported SF36 scores in the physical health (p = 0.002), social functioning (p = 0.03) and general health (p = 0.009) domains. Women had an overall lower self-perceived QoL.

Conclusions: Symptomatic presentation at CeD diagnosis, diagnostic delay and sex may affect QoL and psychological disorders.

Citing Articles

Physical and psychological symptoms and survey importance in celiac disease.

Ciaccio E, Lee A, Lebovits J, Wolf R, Lewis S World J Gastrointest Endosc. 2024; 16(12):632-639.

PMID: 39735391 PMC: 11669964. DOI: 10.4253/wjge.v16.i12.632.


Resilience in Adult Coeliac Patients on a Gluten-Free Diet: A Cross-Sectional Multicentre Italian Study.

Schiepatti A, Maimaris S, Randazzo S, Maniero D, Biti R, Caio G Nutrients. 2024; 16(16).

PMID: 39203732 PMC: 11357567. DOI: 10.3390/nu16162595.


Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease.

Crepaldi M, Palo M, Maniero D, Bertin L, Savarino E, Anderson R Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38275990 PMC: 10821495. DOI: 10.3390/ph17010004.


The Gluten-Free Diet for Celiac Disease: Critical Insights to Better Understand Clinical Outcomes.

Simon E, Molero-Luis M, Fueyo-Diaz R, Costas-Batlle C, Crespo-Escobar P, Montoro-Huguet M Nutrients. 2023; 15(18).

PMID: 37764795 PMC: 10537989. DOI: 10.3390/nu15184013.


Health utilities and willingness to pay in adult patients with coeliac disease in Hungary.

Angyal M, Lakatos P, Jenei B, Brodszky V, Rencz F Qual Life Res. 2023; 32(9):2503-2516.

PMID: 37067657 PMC: 10393904. DOI: 10.1007/s11136-023-03418-w.